Robert Furchgott Louis J. Ignarro
Ferid Murad
• Nitric oxide is a diatomic free radical consisting of one atom of
nitrogen and one atom of oxygen
• Lipid soluble and very small for easy passage between cell
membranes
• Short lived, usually degraded or reacted within a few seconds
• The natural form is a gas
•First described in 1979 as a potent relaxant of peripheral
vascular smooth muscle.
•Used by the body as a signaling molecule.
•Serves different functions depending on body system. i.e.
neurotransmitter, vasodilator, bactericide.
•Environmental Pollutant
•First gas known to act as a biological messenger
TOXIC
STAY
AWAY
WITHOUT THIS,
YOU
WILL DIE!
Functional NOS is a dimer formed of 2 identical subunits. Each subunit consists of 3 distinct
Domains.
1. The Reductase Domain: C-terminal, 600-
residue that supplies the electrons to
oxygenase domain for the NOS reaction.
2 . Calmodulin Binding Domain: Calmodulin
binding is required for the activity of all the
NOS isoforms.
3. The Oxygenase Domain: N-terminal, 500
residue, heme domain that catalyzes 2 steps
for conversion of arginine into citrulline and
nitric oxide.
NOS-catalyzed two-stage oxidation of L-arginine (Arg) to L-citrulline (Cit) and NO via
the stable intermediate Nω-hydroxy-L-arginine (NOHA).
Types of NOS Isoforms
1. nNOS- (Neuronal NOS / Type I / NOS-1) isoform first found in neuronal tissue.
2. iNOS- (Inducible NOS / Type II / NOS-2) isoform which is inducible in a wide range
of cells and tissues.
3. eNOS- (Endothelial NOS / Type III / NOS-3) isoform first found in vascular
endothelial cells.
4.Encoded by different genes with different localization, , catalytic properties and
inhibitor sensitivity.
5.They exhibit 51-57% homology.
CONT….
Human NOS Isoform
nNOS iNOS eNOS
Expression Constitutive Inducible Constitutive
Protein size 1434 aa 1153 aa 1203 aa
Protein weight 161kDa 131kDa 133kDa
Enzyme activity Ca2+ dependent Ca2+ independent Ca2+ dependent
Chromosomal location 12 17 7
• Nitric Oxide in the human body has many uses which are best
summarized under five categories.
• NO in the nervous system
• NO in the circulatory system
• NO in the muscular system
• NO in the immune system
• NO in the digestive system
Nitric oxide as a neurotransmitter
NO is a signaling molecule, but not necessarily a neurotransmitter
NO signals inhibition of smooth muscle contraction, adaptive relaxation, and
localized vasodilation
Nitric oxide believed to play a role in long term memory
Memory mechanism proposed is a retrograde messenger that facilitates long
term potentiation of neurons (memory)
Synthesis mechanism involving Ca/Calmodulin activates NOS-I
NO travels from postsynaptic neuron back to presynaptic neuron which
activates guanylyl cyclase, the enzyme that catalyzes cGMP production
This starts a cycle of nerve action potentials driven by NO
• NO serves in the body as a neurotransmitter, but there are
definite differences between other neurotransmitters used
commonly in the body
• NO is synthesized on demand vs. constant synthesis
• NO diffuses out of the cells making it vs. storage in vesicles and release by
exocytosis
• NO does not bind to surface receptors, but instead exits cytoplasm, enters the
target cell, and binds with intracellular guanylyl cyclase
• Similarities to normal NTs
• Present in presynaptic terminal
• Natural removal from synaptic junction
• NO serves as a vasodilator
• Released in response to high blood flow rate and signaling molecules (Ach
and bradykinin)
• Highly localized and effects are brief
• If NO synthesis is inhibited, blood pressure
• NO aids in gas exchange between hemoglobin and cells
• Hemoglobin is a vasoconstrictor, Fe scavenges NO
• NO is protected by cysteine group when O2 binds to hemoglobin
• During O2 delivery, NO locally dilates blood vessels to aid in gas exchange
• Excess NO is picked up by HGB with CO2
NO was orginally called EDRF (endothelium derived relaxation factor)
NO signals inhibition of smooth muscle contraction
Ca+2 is released from the vascular lumen activating NOS
NO is synthesized from NOS III in vascular endothelial cells
This causes guanylyl cyclase to produce cGMP
A rise in cGMP causes Ca+2 pumps to be activated, thus reducing Ca+2
concentration in the cell
This causes muscle relaxation
• NOS II catalyzes synthesis of NO used in host defense reactions
• Activation of NOS II is independent of Ca+2 in the cell
• Synthesis of NO happens in most nucleated cells, particularly
macrophages
• NO is a potent inhibitor of viral replication
• NO is a bactericidal agent
• NO is created from the nitrates extracted from food near the gums
• This kills bacteria in the mouth that may be harmful to the body
•NO is used in adaptive relaxation
• NO promotes the stretching of the stomach in response to
filling.
• When the stomach gets full, stretch receptors trigger
smooth muscle relaxation through NO releasing neurons
•Which post-translational modifications are significant in
the regulation of the three isoforms ?
•What is the significance and basis of the sub-cellular
localization of the NOSs ?
•Will selective iNOS, nNOS or dual iNOS-nNOS
inhibitors prove to be of value in the treatment of human
diseases, and if so, which diseases, and what side-effects
might result ?
1st enzyme to synthesize a gas Nitric Oxide, a signalling molecule.
A very complex enzyme with six co-factors and three distinct
isoforms.
It has bidomain structure and formation of a dimer is essential for its
activation.
There are a number of NOS signalled pathways associated with many
biochemical and physiological processes
If you would like to donate us?
Scan below and donate us 0.013$ (US dollar) (5Rs Indian rupee)
Contact: If you want PPT/PDF files, please contact below.
Email: gnccmysore@gmail.com
Telegram:+919738137533(only for Chat)
Nitric oxide  ppt.pptx

Nitric oxide ppt.pptx

  • 2.
    Robert Furchgott LouisJ. Ignarro Ferid Murad
  • 3.
    • Nitric oxideis a diatomic free radical consisting of one atom of nitrogen and one atom of oxygen • Lipid soluble and very small for easy passage between cell membranes • Short lived, usually degraded or reacted within a few seconds • The natural form is a gas
  • 4.
    •First described in1979 as a potent relaxant of peripheral vascular smooth muscle. •Used by the body as a signaling molecule. •Serves different functions depending on body system. i.e. neurotransmitter, vasodilator, bactericide. •Environmental Pollutant •First gas known to act as a biological messenger TOXIC STAY AWAY WITHOUT THIS, YOU WILL DIE!
  • 5.
    Functional NOS isa dimer formed of 2 identical subunits. Each subunit consists of 3 distinct Domains. 1. The Reductase Domain: C-terminal, 600- residue that supplies the electrons to oxygenase domain for the NOS reaction. 2 . Calmodulin Binding Domain: Calmodulin binding is required for the activity of all the NOS isoforms. 3. The Oxygenase Domain: N-terminal, 500 residue, heme domain that catalyzes 2 steps for conversion of arginine into citrulline and nitric oxide.
  • 6.
    NOS-catalyzed two-stage oxidationof L-arginine (Arg) to L-citrulline (Cit) and NO via the stable intermediate Nω-hydroxy-L-arginine (NOHA).
  • 7.
    Types of NOSIsoforms 1. nNOS- (Neuronal NOS / Type I / NOS-1) isoform first found in neuronal tissue. 2. iNOS- (Inducible NOS / Type II / NOS-2) isoform which is inducible in a wide range of cells and tissues. 3. eNOS- (Endothelial NOS / Type III / NOS-3) isoform first found in vascular endothelial cells. 4.Encoded by different genes with different localization, , catalytic properties and inhibitor sensitivity. 5.They exhibit 51-57% homology.
  • 8.
    CONT…. Human NOS Isoform nNOSiNOS eNOS Expression Constitutive Inducible Constitutive Protein size 1434 aa 1153 aa 1203 aa Protein weight 161kDa 131kDa 133kDa Enzyme activity Ca2+ dependent Ca2+ independent Ca2+ dependent Chromosomal location 12 17 7
  • 9.
    • Nitric Oxidein the human body has many uses which are best summarized under five categories. • NO in the nervous system • NO in the circulatory system • NO in the muscular system • NO in the immune system • NO in the digestive system
  • 10.
    Nitric oxide asa neurotransmitter NO is a signaling molecule, but not necessarily a neurotransmitter NO signals inhibition of smooth muscle contraction, adaptive relaxation, and localized vasodilation Nitric oxide believed to play a role in long term memory Memory mechanism proposed is a retrograde messenger that facilitates long term potentiation of neurons (memory) Synthesis mechanism involving Ca/Calmodulin activates NOS-I NO travels from postsynaptic neuron back to presynaptic neuron which activates guanylyl cyclase, the enzyme that catalyzes cGMP production This starts a cycle of nerve action potentials driven by NO
  • 11.
    • NO servesin the body as a neurotransmitter, but there are definite differences between other neurotransmitters used commonly in the body • NO is synthesized on demand vs. constant synthesis • NO diffuses out of the cells making it vs. storage in vesicles and release by exocytosis • NO does not bind to surface receptors, but instead exits cytoplasm, enters the target cell, and binds with intracellular guanylyl cyclase • Similarities to normal NTs • Present in presynaptic terminal • Natural removal from synaptic junction
  • 12.
    • NO servesas a vasodilator • Released in response to high blood flow rate and signaling molecules (Ach and bradykinin) • Highly localized and effects are brief • If NO synthesis is inhibited, blood pressure • NO aids in gas exchange between hemoglobin and cells • Hemoglobin is a vasoconstrictor, Fe scavenges NO • NO is protected by cysteine group when O2 binds to hemoglobin • During O2 delivery, NO locally dilates blood vessels to aid in gas exchange • Excess NO is picked up by HGB with CO2
  • 13.
    NO was orginallycalled EDRF (endothelium derived relaxation factor) NO signals inhibition of smooth muscle contraction Ca+2 is released from the vascular lumen activating NOS NO is synthesized from NOS III in vascular endothelial cells This causes guanylyl cyclase to produce cGMP A rise in cGMP causes Ca+2 pumps to be activated, thus reducing Ca+2 concentration in the cell This causes muscle relaxation
  • 15.
    • NOS IIcatalyzes synthesis of NO used in host defense reactions • Activation of NOS II is independent of Ca+2 in the cell • Synthesis of NO happens in most nucleated cells, particularly macrophages • NO is a potent inhibitor of viral replication • NO is a bactericidal agent • NO is created from the nitrates extracted from food near the gums • This kills bacteria in the mouth that may be harmful to the body
  • 16.
    •NO is usedin adaptive relaxation • NO promotes the stretching of the stomach in response to filling. • When the stomach gets full, stretch receptors trigger smooth muscle relaxation through NO releasing neurons
  • 17.
    •Which post-translational modificationsare significant in the regulation of the three isoforms ? •What is the significance and basis of the sub-cellular localization of the NOSs ? •Will selective iNOS, nNOS or dual iNOS-nNOS inhibitors prove to be of value in the treatment of human diseases, and if so, which diseases, and what side-effects might result ?
  • 18.
    1st enzyme tosynthesize a gas Nitric Oxide, a signalling molecule. A very complex enzyme with six co-factors and three distinct isoforms. It has bidomain structure and formation of a dimer is essential for its activation. There are a number of NOS signalled pathways associated with many biochemical and physiological processes
  • 19.
    If you wouldlike to donate us? Scan below and donate us 0.013$ (US dollar) (5Rs Indian rupee) Contact: If you want PPT/PDF files, please contact below. Email: gnccmysore@gmail.com Telegram:+919738137533(only for Chat)

Editor's Notes

  • #15 Nitric Oxide (NO) produced in the endothelial cells is involved in vasorelaxation, platelet aggregation, and mechanisms of cardiovascular homeostasis. Activation of endothelial acetylcholine receptors activate phospholipase C (PLC) that catalyzes the production of inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) from phosphatidylinositol 4,5-bisphosphate (PIP2). The IP3-induced increase in intracellular Ca2+ activates calmodulin that binds to eNOS, which dissociates from caveolin and translocates to the cytoplasm. Phosphorylation of eNOS by protein kinase A (PKA) inactivates the enzyme, which then relocates to the membrane caveoli.
  • #18 the supporting evidence varies in both quantity and quality.